SEC 13F Intelligence

Bridger Management, LLC / AKRO

Bridger Management, LLC’s Akero Therapeutics Inc Com Position

Does Bridger Management, LLC own Akero Therapeutics Inc Com (AKRO)? Not currently — the last reported position was 101.5K shares worth $5M in Q3 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$5M
Q3 2023
Shares
101.5K
% of Portfolio
+1.89%
Quarters Held
1
position exited

Position History AKRO

Reported value by quarter
Q3 ’23: $5MQ3 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2023101.5K$5M+1.89%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bridger Management, LLC’s full portfolio or all institutional holders of AKRO.